Scientific work

Prof. Dr. İlhan Tarkun

33 publications. The source of the information is stated next to each publication.

Back to profile

  1. Selek A., Çetinarslan B., Cantürk Z., Tarkun İ., Akyay OZ., Çabuk B., Ceylan S., The Utility of Preoperative ACTH/Cortisol Ratio for the Diagnosis and Prognosis of Cushing's Disease, J. Neurosci Rural Pract. 2018 Jan-Mar; 9(1): 106-11. doi: 0.4103/jnrp.jnrp_308_17.

    Source: anadolusaglik.org profile page

  2. Gürkan E., Tarkun İ.*, Şahin T., Effect of Exenatide on Aortic Stiffness and Blood Pressure Parameters. Turkish Journal of Endoc. Metab. 2017 21(4); 97-103.

    Source: anadolusaglik.org profile page

  3. İ. Tarkun, S. Dumanlı Attitudes, wishes, and needs of diabetes patients and their relatives: Turkish data from the DAWN2 study. Turkish J. Med Sci 2017 Apr 18;47(2):447-45.

    Source: anadolusaglik.org profile page

  4. Karci AC, Canturk Z, Tarkun İ., Çetinarslan B., Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.

    Source: anadolusaglik.org profile page

  5. Selek A, Çetinarslan B, Tarkun İ, Cantürk Z, Üstüner B, Akyay Z., Thyroid autoimmunity: is really associated with papillary thyroid carcinoma? Eur Arch Otorhinolaryngol. 2017 Mar; 274(3): 1677-1681.

    Source: anadolusaglik.org profile page

  6. Selek A., Barış S., Çetinarslan B., Cantürk Z., Tarkun İ., Akyay Z., New-Onset Sarcoidosis After Remission of Cushing's Syndrome. Turk Thorac J. 2016 Jan;17(1):35-37.

    Source: anadolusaglik.org profile page

  7. Selek A., Çetinarslan B., Kıvrakoğlu E., Karadağ DT., Tarkun İ., Cantürk Z., Akyay OZ., Histologic outcome of thyroid nodules with repeated diagnosis of atypia in thyroid fine-needle aspiration biopsy. Future Oncol. 2016 Mar; 12(6): 801-5.

    Source: anadolusaglik.org profile page

  8. Selek A., Çetinarslan B., Gürbüz Y., Tarkun İ., Cantürk Z., Çabuk B. Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis. Endocrine 2015 May; 49(1):250-7.

    Source: anadolusaglik.org profile page

  9. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J., Josse R., Kaufman KD, Koglin J., Korn S., Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S., Van de Werf F., Peterson ED, Holman RR; TECOS Study Group. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N. Engl J. Med. 2015 Jul 16;373(3):232-42.

    Source: anadolusaglik.org profile page

  10. Gürkan E., Tarkun İ., Şahin T., Çetinarslan B., Cantürk Z., Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers. Diabetes Res Clin Pract. 2014 Dec;106(3): 567-75.

    Source: anadolusaglik.org profile page

  11. Gürkan E., Gürbüz Y., Tarkun İ., Cantürk Z., Çetinarslan B. Mixed medullary-papillary carcinoma of the thyroid: report of two cases and review of the literature. Indian J. Pathol Microbiol. 2014 Oct-Dec;57(4):598-602

    Source: anadolusaglik.org profile page

  12. Komşuoglu Çelikyurt I., Mutlu O., Ulak G., Uyar E., Bektaş E., Yıldız Akar F., Erden F., Tarkun İ., Exenatide treatment exerts anxiolytic- and antidepressant-like effects and reverses neuropathy in a mouse model of type-2 diabetes. Med Sci Monit Basic Res. 2014 Jul 30; 20: 112-7.

    Source: anadolusaglik.org profile page

  13. Nicolucci A., Kovacs Burns K., Holt RI., Comaschi M., Hermanns N., Ishii H., Kokoszka A., Pouwer F., Skovlund SE., Stuckey H., Tarkun İ., Vallis M., Wens J., Peyrot M Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. DAWN2 Study Group. Diabet Med. 2013 Jul; 30(7): 767-77.

    Source: anadolusaglik.org profile page

  14. Holt RI, Nicolucci A., Kovacs Burns K., Escalante M., Forbes A., Hermanns N, Kalra S., Massi-Benedetti M., Mayorov A., Menéndez-Torre E., Munro N., Skovlund SE., Tarkun İ., Wens J., Peyrot M. Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care-healthcare professional perspective.;. Diabet Med. 2013 Jul; 30(7): 789-98.

    Source: anadolusaglik.org profile page

  15. Kovacs Burns K., Nicolucci A, Holt RI., Willaing I, Hermanns N., Kalra S., Wens J., Pouwer F., Skovlund SE, Peyrot M.; DAWN2 Study Group Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking indicators for family members living with people with diabetes. Diabet Med. 2013 Jul; 30(7): 778-88.

    Source: anadolusaglik.org profile page

  16. Emre Dikmen, İlhan Tarkun, Zeynep Cantürk, Berrin Çetinarslan, Plasma visfatin level in women with polycystic ovary syndrome. Gynecological Endocrinology 27(7): 475-479, 2011.

    Source: anadolusaglik.org profile page

  17. Emre Dikmen, İlhan Tarkun, Funda Öztürk, Berrin Arslan, Zeynep Cantürk. Plasma adiponectin and resistin levels in women with polycystic ovary syndrome: relation to body mass index and insulin resistance. Turkish Journal of Medical Sciences 41(1): 45-52, 2011.

    Source: anadolusaglik.org profile page

  18. Erdem Türemen, Berrin Çetinarslan, Tayfun Şahin, Zeynep Cantürk, İlhan Tarkun. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocrine Journal 58(5): 349-354, 2011.

    Source: anadolusaglik.org profile page

  19. Tarkun İ, Dikmen E,, Cetinarslan B,, Cantürk Z., Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome. European Cytokine Network 21(4); 272-77.

    Source: anadolusaglik.org profile page

  20. Türemen E., Arslan B., Tarkun İ., Cantürk Z., “Cushingoid stria and Cushingoid appearance in a patient with incidentaloma.” Endocrine Practice, 12 (1):103-104 (2006) .

    Source: anadolusaglik.org profile page

  21. Tarkun İ., Çetinarslan B., Türemen E., Şahin T., Cantürk Z., “Effect of Rosiglitazone on insulin resistance, C-reactive protein and endothelial function in nonobese young women with PCOS” European Journal of Endocrinology, 153, 115-121 (2005).

    Source: anadolusaglik.org profile page

  22. Tarkun İ., Hacıhanefioğlu A., Tarkun P., Çetinarslan B., Cantürk Z. “Anticardiolipin and anti-β2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus”, Diabetes Research and Clinical Practice, 68, 181-187 (2005).

    Source: anadolusaglik.org profile page

  23. Özdemir G, Özden M, Maral H, Kuskay S, Çetinalp P, Tarkun İ. “Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.” Annals of Clinical Biochemistry 42, 99-104 (2005).

    Source: anadolusaglik.org profile page

  24. Tarkun İ., Arslan B., Cantürk Z., Türemen E., Şahin T., Duman C. “Endothelial dysfunction in young women with polycystic ovary syndrome: Relationship with insulin resistance and low-grade chronic inflammation”, Journal of Clinical Endocrinology and Metabolism, 89, 5592-5596 (2004) ( Bu yayının özeti aşağıdaki dergi tarafından JCEM’ den izin alınarak ve editör yorumu eklenerek Obstetrical and Gynecological Survey 60, 180-181, 2005 yayınlanmıştır).

    Source: anadolusaglik.org profile page

  25. Tarkun İ., Cantürk Z., Arslan B., Türemen E., Tarkun P. “The plasminogen activator system in young and lean women with polycystic ovary syndrome”, Endocrine Journal, 51, 467-472 (2004).

    Source: anadolusaglik.org profile page

  26. Şengül E., Çetinarslan B., Tarkun İ., Cantürk B., Türemen E. “Homocysteine concentrations in subclinical hypothyroidism”, Endocrine Research, 30, 351-359 (2004).

    Source: anadolusaglik.org profile page

  27. Tarkun İ., Çetinarslan B., Cantürk Z., Tarkun P., Ağaçdiken A., Komşuoğlu B. “Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: A predictive marker”, Journal of Diabetes and its Complications, 18, 165-168 (2004).

    Source: anadolusaglik.org profile page

  28. Cantürk Z., Çetinarslan B., Tarkun İ., Cantürk N.Z., Özden M. “Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyrodism”, Endocrine Research, 29, 307-16 (2003).

    Source: anadolusaglik.org profile page

  29. Cantürk Z., Çetinarslan B., Tarkun İ., Cantürk N.Z. “Serum ferritin levels in poorly and well controlled diabetes mellitus”, Endocrine Research, 29, 299-306 (2003).

    Source: anadolusaglik.org profile page

  30. Cantürk Z., Çetinarslan B., Tarkun İ., Cantürk N.Z., Özden M., Duman C. “Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism”, Thyroid ,13, 971-7 (2003).

    Source: anadolusaglik.org profile page

  31. Cantürk Z., Cantürk N.Z., Çetinarslan B., Utkan N.Z., Tarkun İ., “Nosocomial infections and obesity in surgical patients”, Obesity Research, 11, 760-75 (2003).

    Source: anadolusaglik.org profile page

  32. Çetinarslan B., Akkoyun M., Cantürk Z., Tarkun İ., Kahraman G., Komsuoğlu B. “Duration of the P wave dispersion in subclinical hyperthyroidism”, Endocrine Practice, 9, 200-203 (2003).

    Source: anadolusaglik.org profile page

  33. Tarkun İ., Çetinarslan B., Cantürk Z. “Lipoprotein (a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications”, Nutrition Metabolism and Cardiovascular Disease, 12, 127-131 (2002). Uluslararası ve ulusal kongrelerde sunulmuş 150' yi aşkın sözel ve poster bildiri. Yayınlar; 2018 yılı itibariyle 1200’ ün üzerinde atıf almıştır.

    Source: anadolusaglik.org profile page